Jan Bubenik
Impact in
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 104
- Immunotherapy and Immune Responses 85
- Immune Cell Function and Interaction 32
-
- Cancer Research and Treatments 24
- Co-authors
- Peter Perlmann (5 shared papers)K Helmstein (2 shared papers)Gunnar Moberger (2 shared papers)M Indrová (59 shared papers)Jana Šímová (46 shared papers)J Jakoubková (5 shared papers)Magdalena Barešová (4 shared papers)V. Viklický (2 shared papers)
In The Last Decade
Jan Bubenik
154 papers receiving 2.5k citations
Jan Bubenik's Hit Papers
Peers
Comparison fields: 5 of 106
- Immunology 1.6k
- Oncology 801
- Biotechnology 187
- Genetics 439
- Molecular Biology 786
Countries citing papers authored by Jan Bubenik
This map shows the geographic impact of Jan Bubenik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Bubenik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Bubenik more than expected).
Fields of papers citing papers by Jan Bubenik
This network shows the impact of papers produced by Jan Bubenik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Bubenik. The network helps show where Jan Bubenik may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Bubenik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 162 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Established cell line of urinary bladder carcinoma (T24) containing tumour‐specific antigen Hit paper breakdown → | 1973 | 472 |
| 2 | 1970 | 264 | |
| 3 | 1970 | 177 | |
| 4 | 2004 | 135 | |
| 5 | 2003 | 107 | |
| 6 | 1974 | 83 | |
| 7 | 1990 | 78 | |
| 8 | 2007 | 74 | |
| 9 | 1988 | 70 | |
| 10 | 1983 | 56 | |
| 11 | 1971 | 51 | |
| 12 | 2001 | 39 | |
| 13 | 2011 | 38 | |
| 14 | 2004 | 36 | |
| 15 | 1967 | 36 | |
| 16 | 1999 | 36 | |
| 17 | 1978 | 31 | |
| 18 | 1996 | 29 | |
| 19 | Factors influencing the induction of enhancement and resistance to methylcholanthrene-induced tumours in a syngenic system. | 1965 | 28 |
| 20 | 1997 | 27 |
About Jan Bubenik
Jan Bubenik is a scholar working on Immunology, Biotechnology, Genetics, Oncology and Molecular Biology, having authored 162 papers that have together received 2.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (85 papers), Virus-based gene therapy research (45 papers), Immune Cell Function and Interaction (32 papers), Cancer Research and Treatments (24 papers), RNA Interference and Gene Delivery (23 papers), CAR-T cell therapy research (20 papers), Cervical Cancer and HPV Research (17 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). The work is most often cited by research in Immunology (1.6k citations), Oncology (801 citations), Biotechnology (187 citations), Genetics (439 citations) and Molecular Biology (786 citations). Jan Bubenik has collaborated with scholars based in Czechia, Russia and Sweden. Frequent co-authors include Peter Perlmann, K Helmstein, Gunnar Moberger, M Indrová, Jana Šímová, J Jakoubková, Magdalena Barešová, V. Viklický, H Sainerová and T Jandlová. Their work appears in journals such as International Journal of Oncology, International Journal of Cancer, Immunology Letters, Cancer Immunology Immunotherapy and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.